| A comparison of rate control and rhythm control in patients with atrial fibrillation Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM ... New England Journal of Medicine 347 (23), 1825-1833, 2002 | 5779 | 2002 |
| ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary a report of the American College of Cardiology/American Heart Association task … Committee Members, V Fuster, LE Rydén, RW Asinger, DS Cannom, ... Circulation 104 (17), 2118-2150, 2001 | 2981* | 2001 |
| Rhythm control versus rate control for atrial fibrillation and heart failure D Roy, M Talajic, S Nattel, DG Wyse, P Dorian, KL Lee, MG Bourassa, ... New England Journal of Medicine 358 (25), 2667-2677, 2008 | 2100 | 2008 |
| A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators New England Journal of Medicine 337 (22), 1576-1584, 1997 | 1629 | 1997 |
| Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study Affirm Investigators Circulation 109 (12), 1509-1513, 2004 | 1577 | 2004 |
| Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction Cardiac Arrhythmia Suppression Trial II Investigators* New England Journal of Medicine 327 (4), 227-233, 1992 | 1128 | 1992 |
| Management of patients with atrial fibrillation: a statement for healthcare professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart … EN Prystowsky, DW Benson Jr, V Fuster, RG Hart, GN Kay, RJ Myerburg, ... Circulation 93 (6), 1262-1277, 1996 | 985 | 1996 |
| The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study TV Glotzer, EG Daoud, DG Wyse, DE Singer, MD Ezekowitz, C Hilker, ... Circulation: Arrhythmia and Electrophysiology 2 (5), 474-480, 2009 | 984 | 2009 |
| Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop EJ Benjamin, PS Chen, DE Bild, AM Mascette, CM Albert, A Alonso, ... Circulation 119 (4), 606-618, 2009 | 592 | 2009 |
| Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. JT Hii, DG Wyse, AM Gillis, HJ Duff, MA Solylo, LB Mitchell Circulation 86 (5), 1376-1382, 1992 | 577 | 1992 |
| Influence of race, sex, and age on management of unstable angina and non—Q-wave myocardial infarction: The TIMI III Registry PH Stone, B Thompson, HV Anderson, MW Kronenberg, RS Gibson, ... Jama 275 (14), 1104-1112, 1996 | 504 | 1996 |
| Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial DV Exner, SL Pinski, DG Wyse, EG Renfroe, D Follmann, M Gold, ... Circulation 103 (16), 2066-2071, 2001 | 487 | 2001 |
| The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation JG Andrade, M Aguilar, C Atzema, A Bell, JA Cairns, CC Cheung, JL Cox, ... Canadian Journal of Cardiology 36 (12), 1847-1948, 2020 | 477 | 2020 |
| Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial D Roy, CM Pratt, C Torp-Pedersen, DG Wyse, E Toft, S Juul-Moller, ... Circulation 117 (12), 1518-1525, 2008 | 468 | 2008 |
| Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation DG Wyse N Engl J Med 347, 1825-1833, 2002 | 428 | 2002 |
| Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial LB Mitchell, DV Exner, DG Wyse, CJ Connolly, GD Prystai, AJ Bayes, ... Jama 294 (24), 3093-3100, 2005 | 398 | 2005 |
| Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS EG Daoud, TV Glotzer, DG Wyse, MD Ezekowitz, C Hilker, J Koehler, ... Heart rhythm 8 (9), 1416-1423, 2011 | 351 | 2011 |
| Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial PJ Devereaux, E Duceppe, G Guyatt, V Tandon, R Rodseth, BM Biccard, ... The Lancet 391 (10137), 2325-2334, 2018 | 307 | 2018 |
| International consensus on nomenclature and classification of atrial fibrillation: a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac … S Lévy, AJ Camm, S Saksena, E Aliot, G Breithardt, H Crijns, W Davies, ... Europace 5 (2), 119-122, 2003 | 301 | 2003 |
| Lone atrial fibrillation: does it exist? DG Wyse, IC Van Gelder, PT Ellinor, AS Go, JM Kalman, SM Narayan, ... Journal of the American College of Cardiology 63 (17), 1715-1723, 2014 | 283 | 2014 |
